South African Institute of Drug-Free Sport position statement on CBD (Cannabidiol) and THC (Tetrahydrocannabinol)
dc.contributor.author | Pillay, Lervasen | |
dc.contributor.author | Janse van Rensburg, Dina Christina | |
dc.contributor.author | Swart, Jeroen | |
dc.contributor.author | Hendricks, Sharief | |
dc.contributor.author | Thompson, Craig | |
dc.contributor.author | Tabane, Carl | |
dc.contributor.author | Kirby, Jo-Anne | |
dc.contributor.author | Zondi, Phathokuhle | |
dc.contributor.author | Rotunno, Adrian | |
dc.contributor.author | Bayever, David | |
dc.date.accessioned | 2023-10-10T05:12:43Z | |
dc.date.available | 2023-10-10T05:12:43Z | |
dc.date.issued | 2023-10 | |
dc.description.abstract | Cannabidiol (CBD) and Tetrahydrocannabinol (THC) have become easily available to athletes over the years. Using these substances may inadvertently expose an athlete to the possibility of an adverse analytical finding (a ”positive” test) and a sanction. Athletes need to understand the risk of an antidoping rule violation or adverse analytical finding should these products be used, especially if no therapeutic use exemption exists. This position statement attempts to clarify the use of CBD and THC and their associated risks with Anti-Doping Rule Violations (ADRV) in the athletic population. The South African Sports Medicine Association supports this position statement. | en_US |
dc.description.department | Sports Medicine | en_US |
dc.description.librarian | hj2023 | en_US |
dc.description.uri | https://journals.assaf.org.za/index.php/sajsm/index | en_US |
dc.identifier.citation | Pillay, L., Janse van Rensburg, D. C., Swart, J., Hendricks, S., Thompson, C., Tabane, C., Kirby, J.-A., Zondi, P., Rotunno, A., & Bayever, D. (2023). South African Institute of Drug-Free Sport Position Statement on CBD (Cannabidiol) and THC (Tetrahydrocannabinol). South African Journal of Sports Medicine, 35(1). https://doi.org/10.17159/2078-516X/2023/v35i1a16097. | en_US |
dc.identifier.issn | 2078-516X (online) | |
dc.identifier.issn | 1015-5163 (print) | |
dc.identifier.other | 10.17159/2078-516X/2023/v35i1a16097 | |
dc.identifier.uri | http://hdl.handle.net/2263/92794 | |
dc.language.iso | en | en_US |
dc.publisher | Academy of Science of South Africa | en_US |
dc.rights | © 2023 South African Journal of Sports Medicine. This work is licensed under a Creative Commons Attribution 4.0 International License.. | en_US |
dc.subject | Cannabidiol (CBD) | en_US |
dc.subject | Tetrahydrocannabinol (THC) | en_US |
dc.subject | Adverse analytical finding | en_US |
dc.subject | Athletes | en_US |
dc.subject | Anti-doping rule violation (ADRV) | en_US |
dc.subject | Doping | en_US |
dc.subject | Position statement | en_US |
dc.title | South African Institute of Drug-Free Sport position statement on CBD (Cannabidiol) and THC (Tetrahydrocannabinol) | en_US |
dc.type | Article | en_US |